We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.92B
AUM Growth
+$705M
Cap. Flow
+$556M
Cap. Flow %
11.29%
Top 10 Hldgs %
30.88%
Holding
109
New
27
Increased
28
Reduced
31
Closed
16

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$201M
2
VTRS icon
Viatris
VTRS
+$197M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$167M
4
ELV icon
Elevance Health
ELV
+$92.3M
5
THC icon
Tenet Healthcare
THC
+$70.7M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$84.6M
2
NOW icon
ServiceNow
NOW
+$80.6M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$73.7M
4
CI icon
Cigna
CI
+$60.3M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 59.98%
2 Technology 11.1%
3 Communication Services 4.51%
4 Financials 2.87%
5 Consumer Discretionary 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$198M 4.01%
+3,123,145
New +$201M
VTRS icon
2
Viatris
VTRS
$19.9B
$190M 3.87%
+4,624,079
New +$197M
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$174M 3.53%
5,326,671
-614,384
-10% -$27M
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$15.8B
$171M 3.48%
+1,135,527
New +$167M
AERI
5
DELISTED
Aerie Pharmaceuticals
AERI
$154M 3.12%
2,833,003
+225,792
+9% +$12.6M
ELV icon
6
Elevance Health
ELV
$84.7B
$145M 2.95%
660,870
+393,065
+147% +$92.3M
PBYI icon
7
Puma Biotechnology
PBYI
$415M
$138M 2.81%
2,032,619
+210,819
+12% +$15.8M
BAX icon
8
Baxter International
BAX
$11.4B
$134M 2.73%
2,067,832
+793,815
+62% +$53.7M
UNH icon
9
UnitedHealth
UNH
$394B
$109M 2.22%
511,271
+138,863
+37% +$31.7M
ABT icon
10
Abbott
ABT
$175B
$105M 2.14%
1,756,796
+24,254
+1% +$1.46M
MOH icon
11
Molina Healthcare
MOH
$11.6B
$104M 2.12%
1,286,398
+111,621
+10% +$8.98M
XNTK icon
12
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.14B
$103M 2.1%
+1,178,800
New +$107M
ZBH icon
13
Zimmer Biomet
ZBH
$17.1B
$97.2M 1.98%
918,164
+223,112
+32% +$25.9M
MSFT icon
14
Microsoft
MSFT
$2.89T
$96.5M 1.96%
1,056,879
+739,938
+233% +$67.7M
BMY icon
15
CALL
Bristol-Myers Squibb
BMY
$124B
$92.2M 1.87%
+1,457,500
New +$93.8M
HUM icon
16
Humana
HUM
$47.9B
$86.1M 1.75%
320,450
+25,970
+9% +$7.03M
THC icon
17
Tenet Healthcare
THC
$16.9B
$86.1M 1.75%
+3,550,161
New +$70.7M
BPMC
18
DELISTED
Blueprint Medicines
BPMC
$84.2M 1.71%
917,990
+51,250
+6% +$4.42M
RVTY icon
19
Revvity
RVTY
$12.4B
$81.9M 1.66%
1,081,507
+183,347
+20% +$14.2M
ESPR
20
DELISTED
Esperion Therapeutics
ESPR
$81.7M 1.66%
1,129,998
+259,896
+30% +$19.1M
GDDY icon
21
GoDaddy
GDDY
$11.8B
$79.8M 1.62%
1,299,060
-644,468
-33% -$36.4M
ACOR
22
DELISTED
Acorda Therapeutics
ACOR
$79.3M 1.61%
27,960
-803
-3% -$2.4M
EW icon
23
Edwards Lifesciences
EW
$48.6B
$78.1M 1.59%
1,679,985
-999,864
-37% -$43.4M
PEN icon
24
Penumbra
PEN
$12.5B
$74.8M 1.52%
646,986
-178,526
-22% -$18.4M
MDCO
25
DELISTED
Medicines Co
MDCO
$72.6M 1.47%
2,203,331
+358,279
+19% +$11.2M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q1 2018 Portfolio in Review

As of Q1 2018, PFM Health Sciences held 109 positions worth $4.92B, up 17% from $4.22B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences deployed $556M of net new capital in Q1 2018, opening 27 new positions and adding to 28 existing holdings. Its largest new stake was Bristol-Myers Squibb: 3,123,145 shares worth $198M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 48% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $80.6M trimmed.

  • PFM Health Sciences's largest Q1 2018 buy was Bristol-Myers Squibb: 3,123,145 shares worth $198M.
  • PFM Health Sciences added most to Elevance Health in Q1 2018, an estimated $92.3M increase.
  • PFM Health Sciences's biggest Q1 2018 reduction was ServiceNow, cutting an estimated $80.6M.
  • PFM Health Sciences fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $84.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.92B portfolio in Q1 2018.
  • PFM Health Sciences opened 27 new positions and closed 16 in Q1 2018.
  • PFM Health Sciences's portfolio value rose 17% quarter-over-quarter to $4.92B.

Based on PFM Health Sciences's 13F filing for Q1 2018, filed 15 May 2018.